Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270283
Max Phase: Preclinical
Molecular Formula: C65H74N12O16
Molecular Weight: 1279.37
Associated Items:
ID: ALA5270283
Max Phase: Preclinical
Molecular Formula: C65H74N12O16
Molecular Weight: 1279.37
Associated Items:
Canonical SMILES: CCOC(c1ccc(COCC(=O)NCCOCCOCCOCCOCCOCCNC(=O)CC[C@H](NC(=O)c2ccc(NCc3cnc4nc(N)nc(O)c4n3)cc2)C(=O)O)cc1OC)n1cnc(CCn2c3c(c4ccccc4c2=O)C(=O)c2ccccc2-3)c1
Standard InChI: InChI=1S/C65H74N12O16/c1-3-93-63(76-37-44(71-40-76)20-23-77-57-47-9-5-6-10-48(47)58(80)55(57)46-8-4-7-11-49(46)62(77)83)50-17-12-41(34-52(50)86-2)38-92-39-54(79)68-22-25-88-27-29-90-31-33-91-32-30-89-28-26-87-24-21-67-53(78)19-18-51(64(84)85)73-60(81)42-13-15-43(16-14-42)69-35-45-36-70-59-56(72-45)61(82)75-65(66)74-59/h4-17,34,36-37,40,51,63,69H,3,18-33,35,38-39H2,1-2H3,(H,67,78)(H,68,79)(H,73,81)(H,84,85)(H3,66,70,74,75,82)/t51-,63?/m0/s1
Standard InChI Key: FKTUDWWKEDZGGV-LDKBFXSCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1279.37 | Molecular Weight (Monoisotopic): 1278.5346 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Cushman M.. (2021) Design and Synthesis of Indenoisoquinolines Targeting Topoisomerase I and Other Biological Macromolecules for Cancer Chemotherapy., 64 (24.0): [PMID:34879200] [10.1021/acs.jmedchem.1c01491] |
Source(1):